Chemical Component Summary

NameN-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE
SynonymsPNU-292137 INHIBITOR
IdentifiersN-(5-cyclopropyl-2H-pyrazol-3-yl)-2-naphthalen-2-yl-ethanamide
FormulaC18 H17 N3 O
Molecular Weight291.347
TypeNON-POLYMER
Isomeric SMILESc1ccc2cc(ccc2c1)CC(=O)Nc3cc(n[nH]3)C4CC4
InChIInChI=1S/C18H17N3O/c22-18(19-17-11-16(20-21-17)14-7-8-14)10-12-5-6-13-3-1-2-4-15(13)9-12/h1-6,9,11,14H,7-8,10H2,(H2,19,20,21,22)
InChIKeyRIGZCVNCFXYBEG-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count39
Chiral Atom Count0
Bond Count42
Aromatic Bond Count16

Drug Info: DrugBank

DrugBank IDDB06944 
NameN-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide
Groups experimental
DescriptionN-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide is a solid. This compound belongs to the naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings. The proteins that N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide targets include cyclin-A2 and cyclin-dependent kinase 2.
SynonymsN-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide

Drug Targets

NameTarget SequencePharmacological ActionActions
Cyclin-A2MLGNSAPGPATREAGSALLALQQTALQEDQENINPEKAAPVQQPRTRAAL...unknown
Cyclin-dependent kinase 2MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 449087
ChEMBL CHEMBL115220